Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
HCP Acquires Cambridge Life Science Property for $333M
Real estate investment trust HCP has entered into a definitive agreement to acquire a 224,000-square-foot laboratory building in Cambridge for $332.5 million. The seller was the Davis Companies and Invesco Real Estate.
Located at 35 CambridgePark Dr., the property is adjacent to HCP’s recently acquired property at 87 CambridgePark Dr. and a future development opportunity at 101 CambridgePark Dr. The property is fully-leased to five life science tenants composed of both established large-cap and emerging biopharmaceutical companies.
“With the acquisition of 35 CambridgePark Drive, we’re pleased to report that in less than two years we have expanded our presence in the Boston life science market to more than 1.3 million square feet, and at a very compelling blended yield,” said Scott Brinker, CIO of HCP.
For comments, questions or concerns, please contact David Cohen
- ◦Sale/Acquisition